Trump to announce all 50 states joining Medicaid drug pricing model
Tap title to read story
President Donald Trump announced that all fifty states, the District of Columbia, and Puerto Rico are participating in the Medicaid GENEROUS model, a program designed to implement most favored nation pricing for selected prescription drugs. The initiative aligns U.S. Medicaid net drug prices with lower rates paid in other affluent nations. The administration projects substantial savings over the coming decade, easing financial pressure on state-funded programs. Independent healthcare experts emphasize that actual savings remain unclear because specific manufacturer contract terms are not public. The announcement arrives as cost-of-living concerns dominate voter priorities ahead of the November midterm elections. While Medicaid beneficiaries pay only nominal prescription co-payments, lower net acquisition costs aim to relieve broader public healthcare spending. Critics note that existing federal rebate structures already secure substantial discounts, leaving the precise net fiscal impact subject to verification as state implementation proceeds across the country.